Arnd Christ joined Immatics in October 2020 and brings nearly two decades of experience serving as CFO of both private and public biotechnology companies.
Before joining Immatics, he was CFO of several companies including InflaRX, Medigene AG, Novimmune SA and Probiodrug AG. Over the course of his career, Arnd Christ completed a broad range of corporate transactions including an IPO, capital raises and licensing deals. Prior to serving as a CFO, he held the position of Financial Director in various corporations related to the former Hoechst Group in Germany and the UK. Arnd Christ holds a master’s degree in business administration from the University of Würzburg, Germany.